Tillomed

European pharmaceutical company headquartered in Luton, UK, specializing in licensing and marketing cost-effective generic pharmaceuticals. Grew from 3 products and €5M sales in 2013 to 100+ products and €100M revenue by 2020. Subsidiaries in Spain, Germany and Italy. Part of the Emcure group. Therapy areas: oncology, analgesia, cardiovascular, women's health, anti-infectives, anti-epileptics, GI, GU, immunosuppressants, mental health and osteoporosis.